Insider Trading Alert - OPK, BLL, HOT, APD And IBKR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 7, 2013, 132 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $555.62 to $810,125,000.00.

Highlighted Stocks Traded by Insiders:

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 12,300 shares at $10.30 on Nov. 7, 2013. Following this transaction, the CEO & Chairman owned 136.9 million shares meaning that the stake was reduced by 0.01% with the 12,300 share transaction.

The shares most recently traded at $10.29, down $0.01, or 0.06% since the insider transaction.

The average volume for Opko Health has been 4.8 million shares per day over the past 30 days. Opko Health has a market cap of $4.2 billion and is part of the health care sector and health services industry. Shares are up 114.35% year to date as of the close of trading on Thursday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Ball Corporation (BLL) - FREE Research Report

Bradford Douglas K who is V.P. Financial Reporting & Tax at Ball Corporation sold 525 shares at $49.85 on Nov. 7, 2013. Following this transaction, the V.P. Financial Reporting & Tax owned 22,817 shares meaning that the stake was reduced by 2.25% with the 525 share transaction.

The shares most recently traded at $49.58, down $0.27, or 0.54% since the insider transaction. Historical insider transactions for Ball Corporation go as follows:

  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 17,200

The average volume for Ball Corporation has been 945,500 shares per day over the past 30 days. Shares are up 11.82% year to date as of the close of trading on Thursday.

Ball Corporation, together with its subsidiaries, supplies metal packaging products to the beverage, food, personal care, and household products industries in the United States and internationally. The stock currently has a dividend yield of 1.04%. The company has a P/E ratio of 22.0. Currently there are 2 analysts that rate Ball Corporation a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BLL - FREE

TheStreet Quant Ratings rates Ball Corporation as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, increase in stock price during the past year, growth in earnings per share, notable return on equity and increase in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Ball Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Starwood Hotels & Resorts Worldwide (HOT) - FREE Research Report

Cava Jeffrey M who is EVP & Chief HR Officer at Starwood Hotels & Resorts Worldwide sold 10,000 shares at $74.75 on Nov. 7, 2013. Following this transaction, the EVP & Chief HR Officer owned 34,026 shares meaning that the stake was reduced by 22.71% with the 10,000 share transaction.

The shares most recently traded at $74.02, down $0.73, or 0.98% since the insider transaction. Historical insider transactions for Starwood Hotels & Resorts Worldwide go as follows:

  • 4-Week # shares sold: 26,077
  • 12-Week # shares sold: 47,051
  • 24-Week # shares sold: 48,355

The average volume for Starwood Hotels & Resorts Worldwide has been 1.6 million shares per day over the past 30 days. Starwood Hotels & Resorts Worldwide has a market cap of $14.3 billion and is part of the services sector and leisure industry. Shares are up 30.33% year to date as of the close of trading on Thursday.

Starwood Hotels & Resorts Worldwide, Inc. operates as a hotel and leisure company worldwide. The company operates luxury and upscale full-service hotels, resorts, residences, retreats, select-service hotels, and extended stay hotels under the St. The stock currently has a dividend yield of 1.81%. The company has a P/E ratio of 29.0. Currently there are 12 analysts that rate Starwood Hotels & Resorts Worldwide a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HOT - FREE

TheStreet Quant Ratings rates Starwood Hotels & Resorts Worldwide as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Starwood Hotels & Resorts Worldwide Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Air Products & Chemicals (APD) - FREE Research Report

Baeza Mario who is Director at Air Products & Chemicals sold 1,380 shares at $108.75 on Nov. 7, 2013. Following this transaction, the Director owned 620 shares meaning that the stake was reduced by 69% with the 1,380 share transaction.

The shares most recently traded at $109.55, up $0.80, or 0.73% since the insider transaction. Historical insider transactions for Air Products & Chemicals go as follows:

  • 4-Week # shares bought: 15,000
  • 12-Week # shares bought: 15,000
  • 24-Week # shares bought: 15,000

The average volume for Air Products & Chemicals has been 1.2 million shares per day over the past 30 days. Shares are up 30.83% year to date as of the close of trading on Thursday.

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, performance materials, equipment, and services worldwide. The stock currently has a dividend yield of 2.58%. The company has a P/E ratio of 20.0. Currently there are 9 analysts that rate Air Products & Chemicals a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on APD - FREE

TheStreet Quant Ratings rates Air Products & Chemicals as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, expanding profit margins, solid stock price performance and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Air Products & Chemicals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Interactive Brokers Group (IBKR) - FREE Research Report

Galik Milan who is SVP Software Development at Interactive Brokers Group sold 2,000 shares at $21.50 on Nov. 7, 2013. Following this transaction, the SVP Software Development owned 759,604 shares meaning that the stake was reduced by 0.26% with the 2,000 share transaction.

The shares most recently traded at $21.96, up $0.46, or 2.12% since the insider transaction. Historical insider transactions for Interactive Brokers Group go as follows:

  • 4-Week # shares sold: 14,000
  • 12-Week # shares sold: 53,000
  • 24-Week # shares sold: 111,000

The average volume for Interactive Brokers Group has been 409,500 shares per day over the past 30 days. Interactive Brokers Group has a market cap of $1.1 billion and is part of the financial sector and financial services industry. Shares are up 59.07% year to date as of the close of trading on Thursday.

Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker. The stock currently has a dividend yield of 1.84%. The company has a P/E ratio of 25.3. Currently there are 4 analysts that rate Interactive Brokers Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBKR - FREE

TheStreet Quant Ratings rates Interactive Brokers Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Interactive Brokers Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Home Depot, Lowe's, The Blackstone Group: 'Mad Money' Lightning Round

Home Depot, Lowe's, The Blackstone Group: 'Mad Money' Lightning Round

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Blame the Millennials: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)

Blame the Millennials: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)

Biotech Movers: Paratek, Opko, Endo

Biotech Movers: Paratek, Opko, Endo